Avzivi (Bevacizumab)

Inquire / Price
  • Model Number:
    RL23202402
  • Brand Name:
    Avzivi (普贝希)
  • Origin:
    Biosimilars,china
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    1 Bottle/Box
  • Strength
    25mg/1ml
  • Compositon
    Bevacizumab (贝伐珠单抗)
  • Treatment
    Several Types of Cancer
  • Form
    Injection
  • Brand
    Avzivi (普贝希)
  • Quantity Unit
    100mg/4ml/Box,400mg/16ml/Box
  • Manufacturer
    Bio-Thera Solutions,China

Avzivi® (Bevacizumab-tnjn)  sold under the brand name POBEVCY (普贝希) in China, is a humanized monoclonal antibody that targets VEGF. It specifically binds to VEGF and blocks the binding of VEGF to its receptor, thereby reducing neovascularization, inducing the degradation of existing blood vessels, and thereby inhibiting tumor growth. 

Dec 7, 2023,The FDA has approved the fifth bevacizumab biosimilar, Bio-Thera Solutions’ Avzivi (bevacizumab-tnjn) for the treatment of several types of cancer. Avzivi® (BAT1706) is Bio-Thera Solutions’ second FDA approved product in the United States. Avzivi® is the second biosimilar researched, developed, and manufactured by a Chinese pharmaceutical company to receive FDA approval in the United States.


Link

Poster

Top